System from Quest Diagnostics’ products business is first FDA-cleared Herpes Simplex Virus 1 and 2 test that uses genital swab or cerebrospinal fluid (CSF) specimen collection Quest Diagnostics (NYSE: ...

A 24-year-old gravida 1 para 0 woman presented at 27-1/7 weeks’ gestation with preterm labor and spontaneous rupture of membranes for 2 h. Her pregnancy had been uncomplicated to that point, with ...

Persons who have tested positive for herpes simplex virus type 2 (HSV-2) but do not have symptoms or genital lesions still experience virus shedding during subclinical (without clinical manifestations ...

Please provide your email address to receive an email when new articles are posted on . Despite a decline in herpes simplex virus type 2 infections over the course of decades, researchers calculated ...

Asymptomatic herpes simplex virus type 2 (HSV-2) infection is well described, but its natural history and relative transmissibility remain unclear. In this prospective study, researchers evaluated the ...

Vaccines are one of the most important medical inventions of modern times that have saved and enhanced innumerable lives around the world. Despite the technological advances in vaccine design and ...

Genocea Biosciences announced today that it has initiated a Phase 1/2a clinical study with its lead candidate, GEN-003. GEN-003 is an investigational vaccine designed to stimulate T cell and B cell ...

Serum YKL-40 levels in patients with cervical cancer are elevated compared to patients with cervical intraepithelial neoplasia and healthy controls No significant financial relationships to disclose.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Updated Phase 1/2a results with GEN-003, a vaccine candidate under development by Genocea Biosciences, Inc. (Nasdaq: GNCA) for the treatment of herpes simplex virus ...

Assembly Biosciences Inc. has selected development candidate ABI-5366 to progress to IND-enabling studies from its long-acting herpes simplex virus type 2 (HSV-2) helicase inhibitor program for ...

Patients aged ≥ 18 years with HSV culture-positive persistent (i.e. non-healing) herpetic lesions or who were experiencing culture-positive HSV recurrences (≥ 1 every other month) from seven centres ...